期刊文献+

视听性刺激与性教育在西地那非治疗勃起障碍中的应用 被引量:6

Application of audio-visual sexual stimulation and education in the treatment of erectile dysfunction with sildenafil
暂未订购
导出
摘要 目的探讨视听性刺激与性教育对服用西地那非无效的勃起障碍(ED)患者疗效。方法128例服药无效的ED患者,随机分为两组,治疗组64例接受夫妻性教育并服用西地那非100mg后接受视听性刺激诱导勃起。对照组给予常规门诊性教育,指导服药后的性刺激。治疗8周后后对性功能情况再次进行IIEF评分,评定疗效与安全性。结果完成治疗并进行有关检查者120例,治疗组61例,对照组59例。治疗组显效率、总有效率分别为31.12%、81.96%;对照组则为13.33%、62.71%,统计学处理两组有非常显著性差异(P<0.01)。结论对服用西地那非无效的ED患者,采取性教育和视听刺激诱导勃起,使患者掌握正确的性刺激方法,可明显改善勃起功能,疗效明显优于传统的门诊服药指导。 Objective To study the effects of audio-visual sexual stimulation and education on no responders to sildenafil. Methods 128 no responders to Sildenafil were randomly divided into two groups, treatment group and controls (n=64 each). After sexual education and taking Sildenafil 100mg, audio-visual stimulation was given to induce erection in treatment group. Routine sexual education was given in control. The effect and safety were determined by IIEF after 8 weeks' treatment. Results 61 patients in treatment group and 59 patients in control finished the treatment and the relevant examination. More effective rate and total effective rate were 31.12% and 81.96% in treatment group, while 13.33% and 62.17% in control. According to statistics, the difference between two groups was significant (P〈0.01). Conclusion To apply audio- visual sexual stimulation and education can make no responders to sildenafil master the right method for sexual stimulation and improve erectile dysfunction.
出处 《中国男科学杂志》 CAS CSCD 2006年第3期53-55,共3页 Chinese Journal of Andrology
关键词 勃起功能障碍 物理刺激 性教育 erection dysfunction physical stimulation sexual education
  • 相关文献

参考文献7

  • 1Atiemo HO,Szostak MJ,Sklar GN.Salvage of sildenafil failures referred from primary care physicians.J Urol 2003; 170:2356-2358
  • 2Padma-Nathan H.The current state of care for erectile dysfunction.Contemp Urol 2000; 1(suppl); 4-11
  • 3Trummer H.Oral therapy of erectile dysfuntion.Wien Med Wochenschr 2000; 150(1-2):11-13
  • 4郭应禄,朱积川,潘天明,曹坚,江鱼,王益鑫,姚德鸿,胡礼泉.口服西地那非治疗勃起功能障碍疗效和安全性的临床研究[J].中华泌尿外科杂志,2001,22(7):389-394. 被引量:53
  • 5张元芳.阴茎勃起功能障碍的药物治疗进展[J].中国男科学杂志,2004,18(6):67-70. 被引量:2
  • 6Rosen RC,Seidman SN,Menza MA,et al.Quality of life,mood,and sexual function:a path analytic model of treatment effects in men with erectile dysfunction and depressive symptoms.IntJImpotRes 2004; 16(4):334-340
  • 7Diamond LE,Earle DC,Garcia WD.Co-administration of low doses of intranasal PT-141,a melanocortin receptor agonist,and sildenafil to men with erectile dysfunction results in an enhanced erectile response.Urology 2005; 65(4):755-759

二级参考文献16

  • 1朱积川,姜辉.伐地那非治疗勃起功能障碍的有效性和安全性[J].中华男科学杂志,2004,10(9):704-710. 被引量:10
  • 2Rajagopalan P, Mazzu A, Xia C, et al. Effect of highfat breakfast and moderate-fat evening meal on the pharmacokinetics of vardenafil, an oral phosphodi -esterase-5 inhibitor for the treatment of erectile dysfunction. J Clin Pharmacol 2003; 43(3): 260-167
  • 3Hellstrom WJG, Gittelman M, Karlin G, et al. Vardenafil for treatment of men with erectile dysfunction:efficacy and safety in a randomized,double-blind, placebo-conntrolled trial. J Anisozymes. Drol 2002; 23(6): 763-771
  • 4Goldstein I, Young JM, Fischer J, et al. Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes: a multicenter double-blind placebo-controlled fixed-dose study. Diabetes Care 2003 Mar; 26(3): 77
  • 5Chung AT, Strauss JD, Murpny R, A. et al. Sildenafil.A type 5 cGMP phodiesterase inhibitor. Specifically amplifies endogenous cGMP dependent relaxation in rabbit corpus cavernosum smooth muscle in vitro [J]. J Urol 1998; 160(1): 257-261
  • 6Weiske W H. Invasive diagnosis and therapy arethey still reasonable in the age of sildenafil. Andrology 1999; 31:95
  • 7Patterson B, Bedding A, Jewell H, et al. Dosenormalized pharmacokinetics of singledose tadalafil (IC351) in healthy volunteers. Int J Impot Res 2001; 13: S63.Abstract 14
  • 8Brock G, McMahon C, Chen K, et al. Efficacy and safety of tadalafei for the treatment of erectial dysfunction:Results of integrated analyses. J Urol 2002; 168:1332-1336
  • 9Fulgham P F, Cochran J S, Denman J L, et al. Disappointing initial results with transurethral alorostadil for erectile dysfunction in a urology practice setting. J Urol1998; 160(6): 2041-2046
  • 10Jardin A. Evaluation and treatment of ererctile dysfunction. 1st International consultation on erectile dysfunction,Paris, 1999; 1-3

共引文献53

同被引文献19

引证文献6

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部